BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19961217)

  • 1. Evaluation of the OECD 314B activated sludge die-away test for assessing the biodegradation of pharmaceuticals.
    Ericson JF
    Environ Sci Technol; 2010 Jan; 44(1):375-81. PubMed ID: 19961217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with the OECD 308 transformation test: a human pharmaceutical perspective.
    Ericson JF; Smith RM; Roberts G; Hannah B; Hoeger B; Ryan J
    Integr Environ Assess Manag; 2014 Jan; 10(1):114-24. PubMed ID: 23794155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals.
    Ericson JF
    Environ Sci Technol; 2007 Aug; 41(16):5803-11. PubMed ID: 17874790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment.
    Kern S; Baumgartner R; Helbling DE; Hollender J; Singer H; Loos MJ; Schwarzenbach RP; Fenner K
    J Environ Monit; 2010 Nov; 12(11):2100-11. PubMed ID: 20967365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the removal and biodegradation potential of radiolabeled organic chemicals in activated sludge.
    Shimp RJ; Larson RJ
    Ecotoxicol Environ Saf; 1996 Jun; 34(1):85-93. PubMed ID: 8793324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental risk assessment of medicinal products for human use according to European Commission recommendations.
    Huschek G; Hansen PD; Maurer HH; Krengel D; Kayser A;
    Environ Toxicol; 2004 Jun; 19(3):226-40. PubMed ID: 15101038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the sewage treatment plant model SimpleTreat: use of realistic biodegradability tests in probabilistic model simulations.
    Franco A; Struijs J; Gouin T; Price OR
    Integr Environ Assess Manag; 2013 Oct; 9(4):569-79. PubMed ID: 23423778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.
    Trautwein C; Kümmerer K
    Chemosphere; 2011 Oct; 85(5):765-73. PubMed ID: 21752423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method to study biodegradation kinetics of organic trace pollutants by activated sludge.
    Temmink H; Klapwijk B
    Chemosphere; 2003 Jul; 52(1):221-9. PubMed ID: 12729705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradation of chemicals in a standardized test and in environmental conditions.
    Ahtiainen J; Aalto M; Pessala P
    Chemosphere; 2003 May; 51(6):529-37. PubMed ID: 12615106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
    Laenge R; Steger-Hartmann T; Schweinfurth H
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
    Wajsman D; Rudén C
    J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradability of the X-ray contrast compound diatrizoic acid, identification of aerobic degradation products and effects against sewage sludge micro-organisms.
    Haiss A; Kümmerer K
    Chemosphere; 2006 Jan; 62(2):294-302. PubMed ID: 16039694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of the tricyclic antipsychotic drug chlorpromazine under environmental conditions, identification of its main aquatic biotic and abiotic transformation products by LC-MSn and their effects on environmental bacteria.
    Trautwein C; Kümmerer K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():24-38. PubMed ID: 22342447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultimate biodegradation and elimination of antibiotics in inherent tests.
    Gartiser S; Urich E; Alexy R; Kümmerer K
    Chemosphere; 2007 Mar; 67(3):604-13. PubMed ID: 17166562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzyl-penicillin (Penicillin G) transformation in aqueous solution at low temperature under controlled laboratory conditions.
    Bergheim M; Helland T; Kallenborn R; Kümmerer K
    Chemosphere; 2010 Dec; 81(11):1477-85. PubMed ID: 20926113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.